phase 1_2_initiation
saveMayo Clinic — eflornithine hydrochloride (Phase I/II Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Anaplastic Astrocytoma, Glioblastoma Multiforme (GBM), High-Grade Glioma, Low-Grade Astrocytoma, Malignant Glioma, Oligodendroglioma
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- phase 2 completionkava: Mayo Clinic — kava (Phase II Trial Completion)Apr 30, 2026
- grantMAYO CLINIC ROCHESTER — Establishing the etiology of chronic placental villitis of unknown etiologyApr 1, 2026
- grantMAYO CLINIC ROCHESTER — Overcoming Challenging Clinical Scenarios in Non-invasive Coronary Artery Ima...Apr 1, 2026
- grantMAYO CLINIC ROCHESTER — Transforming ANA Testing: Leveraging Epidemiology and AI to Detect Autoimmune...Apr 1, 2026
- grantMAYO CLINIC ROCHESTER — Molecular mechanisms of sexually dimorphic traits of interstitial cells of Ca...Apr 1, 2026
- grantMAYO CLINIC ROCHESTER — The Lymphoma Epidemiology of Outcomes (LEO) Cohort StudyApr 1, 2026
comments(0)
5-min edit window · permanent after that